Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Aldosterone.php on line 2
Aldosterone
LE WE PMID CA
Aldosterone91Aldosteron

Aldosterone

Arterial hypertension (BASKET)

Cardioprotective agents

Cardiovascular risk

Ciclosporin ttMPT

Endothelial dysfunction

Eplerenone

Heart (Diastolic dysfunction)

Insulin (resistance)

Kidney (Anatomy)

Kidney (Chronic renal failure)

Kidney (Fibrosis)

Kidney (Mesangial cell)

Kidney (Tubulus CCD)

Kidney (Tubulus CNT)

Kidney (Tubulus)

Kir1 1 ROMK

Metabolic syndrome

NADPH oxidase

Nucleus (pore)

Potassium (BASKET)

RAAS (Renin angiotensin system)

Receptor (Mineralcorticoid)

Redox (BASKET)

SGK1

Stress (Neurophysiology)

WNK1

WNK4

1968  
1
Primary aldosteronism: review of 12 cases and present diagnostic criteria.
[5643625] South Med J 61(3): 303-6 (1968)
2008  
2
Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study.
[18490805] Neth J Med 66(5): 220-8 (2008)
2009  
3
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.
[19547646] Dtsch Arztebl Int 106(18): 305-11 (2009)
2004  
4
Aldosterone blockade in cardiovascular disease.
[15367532] Heart 90(10): 1229-34 (2004)
2001  
5
Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.
[11881125] J Renin Angiotensin Aldosterone Syst 2(4): 211-4 (2001)
2001  
6
Diagnosis and management of primary aldosteronism.
[11881117] J Renin Angiotensin Aldosterone Syst 2(3): 156-69 (2001)
1998  
7
The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results.
[9839852] J Clin Periodontol 25(11 Pt 2): 953-8; discussion 978-9 (1998)
2009  
8
Mineralocorticoid receptor blockers and chronic kidney disease.
[19729430] Clin J Am Soc Nephrol 4(10): 1685-91 (2009)
2009  
9
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
[19261819] Clin J Am Soc Nephrol 4(3): 542-51 (2009)
2006  
10
Aldosterone antagonism in chronic kidney disease.
[17699271] Clin J Am Soc Nephrol 1(4): 668-77 (2006)
2010  
11
Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome.
[20448074] Clin J Am Soc Nephrol 5(6): 1132-40 (2010)
2004  
12
Control of aldosterone secretion: a model for convergence in cellular signaling pathways.
[15044681] Physiol Rev 84(2): 489-539 (2004)
2008  
13
A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.
[18292466] Endocr Rev 29(2): 133-54 (2008)
2005  
14
The nongenomic actions of aldosterone.
[15814845] Endocr Rev 26(3): 313-21 (2005)
2001  
15
Nontraditional aspects of aldosterone physiology.
[11701424] Am J Physiol Endocrinol Metab 281(6): E1122-7 (2001)
1955  
16
2004  
17
Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy.
[15525873] Diabetes Metab 30(4): 311-8 (2004)
2007  
18
Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?
[17124364] Endocr J 54(4): 487-95 (2007)
2003  
19
Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
[12746276] Endocrinology 144(6): 2208-13 (2003)
2007  
20
Nongenomic actions of aldosterone on the renal tubule.
[17309947] Hypertension 49(4): 728-39 (2007)
2006  
21
Effects of aldosterone on the vasculature.
[16432039] Hypertension 47(3): 312-8 (2006)
2004  
22
The many targets of aldosterone.
[15007036] Hypertension 43(5): 938-40 (2004)
2008  
23
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.
[18552288] J Clin Endocrinol Metab 93(9): 3266-81 (2008)
2008  
24
A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.
[18685118] J Clin Endocrinol Metab 93(8): 2972-4 (2008)
2005  
25
The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.
[15483077] J Clin Endocrinol Metab 90(1): 72-8 (2005)
2003  
26
Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling.
[12915648] J Clin Endocrinol Metab 88(8): 3637-44 (2003)
2003  
27
Aldosterone: direct effects on and production by the heart.
[12788831] J Clin Endocrinol Metab 88(6): 2376-83 (2003)
2005  
28
The new biology of aldosterone.
[16002531] J Endocrinol 186(1): 1-20 (2005)
2008  
29
Primary aldosteronism: part II: subtype differentiation and treatment.
[18651533] J Nephrol 21(4): 455-62 (2008)
2008  
30
Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling.
[18651532] J Nephrol 21(4): 447-54 (2008)
2001  
31
Hyperaldosteronism: recent concepts, diagnosis, and management.
[11571370] Postgrad Med J 77(912): 639-44 (2001)
2004  
32
Mechanisms of hypertension: the expanding role of aldosterone.
[15284285] J Am Soc Nephrol 15(8): 1993-2001 (2004)
1992  
33
The cellular action of aldosterone in target epithelia.
[1405311] Kidney Int 42(2): 250-64 (1992)
2000  
34
2010  
35
Roles of bone morphogenetic protein-6 in aldosterone regulation by adrenocortical cells.
[20802537] Acta Med Okayama 64(4): 213-8 (2010)
2002  
36
2008  
37
Effects of aldosterone on the heart: beyond systemic hemodynamics?
[18645044] Hypertension 52(3): 462-4 (2008)
2008  
38
Aldosterone and vascular inflammation.
[18172061] Hypertension 51(2): 161-7 (2008)
2005  
39
Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension.
[15956109] Hypertension 46(1): 29-30 (2005)
2004  
40
Review of aldosterone- and angiotensin II-induced target organ damage and prevention.
[14985063] Cardiovasc Res 61(4): 663-70 (2004)
2005  
41
Editorial: aldosterone, normotension, and diastolic dysfunction.
[16148348] J Clin Endocrinol Metab 90(9): 5500-1 (2005)
2007  
42
Aldosterone as a cardiovascular risk hormone.
[17409575] Endocr J 54(3): 359-70 (2007)
2006  
43
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
[16397374] J Pharmacol Sci 100(1): 9-16 (2006)
2011  
44
Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.
[21186336] J Pharmacol Sci 115(1): 1-7 (2011)
2010  
45
New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system.
[20675957] J Pharmacol Sci 113(4): 310-4 (2010)
2008  
46
Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.
[19057124] J Pharmacol Sci 108(4): 399-405 (2008)
2009  
47
Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.
[19151533] J Pharmacol Sci 109(1): 1-6 (2009)
2005  
48
Aldosterone in heart and kidney diseases.
[16422128] Hellenic J Cardiol 46(6): 408-19 (2005)
2002  
49
New ideas about aldosterone signaling in epithelia.
[11880316] Am J Physiol Renal Physiol 282(4): F559-76 (2002)
2007  
50
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
[17429034] Am J Physiol Renal Physiol 293(1): F2-9 (2007)
2009  
51
2009  
52
Regulation of potassium (K) handling in the renal collecting duct.
[18839206] Pflugers Arch 458(1): 157-68 (2009)
2010  
53
Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.
[19631234] Neurosci Biobehav Rev 34(1): 80-6 (2010)
2009  
54
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
[19487712] Ann Intern Med 150(11): 776-83 (2009)
2010  
55
Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
[20226958] Prog Cardiovasc Dis 52(5): 401-9 (2010)
2004  
56
Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.
[15824460] Hypertens Res 27(11): 781-9 (2004)
2004  
57
Unorthodox sites and modes of aldosterone action.
[15016902] News Physiol Sci 19(-): 51-4 (2004)
2006  
58
Why are mineralocorticoid receptor antagonists cardioprotective?
[17075718] Naunyn Schmiedebergs Arch Pharmacol 374(3): 153-62 (2006)
PMC   
59
Aldosterone synthase inhibitors in hypertension: current status and future possibilities.
[24570839] JRSM Cardiovasc Dis 3():2048004014522440 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Aldosterone.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Aldosterone.php on line 92